Oxion Biologics
Sweden - StockholmBiotechnology
Focus: Oxion Biologics is a Swedish biotechnology company focused on co-stimulatory blockade therapy, a specialized immunological approach to disease treatment. Limited public data available on current scale and market position.
Profile data last refreshed 20h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Oxion Biologics
AI assessmentNot HiringNo open roles listed right now. Follow Oxion Biologics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
OX118 or placebo
Immune SystemClinical Trials (1)
NCT07020156A First-in-Human Phase I Trial of OX118 in Healthy Volunteers
Phase 1Help build intelligence for Oxion Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.